Conference Programme

Click on the titles to open the abstract in a new window

09:30

Registration and coffee

10:00

Introduction from Brett Cochrane, DHT Science Director

10:10

Richard Argent, University of Nottingham
Characterising an animal origin-free in vitro model of the human intestinal epithelium for drug permeability studies (abstract S01)

10:35

Faruk Ramadani, Kings College London
An in vitro culture system to study the development and maintenance of human IgE-secreting plasma cells (abstract S02)

11:00

Anderson Brito da Silva, University of Newcastle upon Tyne
Utilising live human peritumoural brain tissue to understand tumour associated seizures (abstract S03)

11:25

Coffee

11:45

Damon Bevan, University of East Anglia
Development of an ex-vivo human skin model for impaired wound healing in diabetes: initial studies including chemokine expression (abstract S04)

12:10

Cleo White, University of Birmingham
Identification of suitable culture medium for the development of an animal-free oral mucosa model (abstract S05)

12:35

Paul Furlong, Aston University
Multi-modal integration of brain function measurements: Compelling evidence for alternatives to animal experimentation (abstract S06)

13:00

Lunch & Poster session

14:00

Helen McLeod and Robyn Duncan, University of Dundee
The future of Thiel embalmed human cadavers as an alternative to training and testing using animals (abstracts S07 and S08)

14:30

Sara Ferluga, Plymouth University
Phosphoproteomic analysis identifies STAT1 as a novel target in meningioma (abstract S10)

15:00

Coffee

15:40

Geoff Pilkington, University of Portsmouth
‘All human’ in vitro blood brain barrier (BBB) modelling: implications for CNS nanoparticle drug delivery and cancer metastasis studies (abstract S11)

16:10

Helen Wheadon, University of Glasgow
Chronic Myeloid Leukaemia tyrosine kinase inhibitor response classification by quantitative RT-PCR (abstract S12)

16:35

Adrian Biddle, Queen Mary University of London
Developing in vitro model systems with demonstrable relevance to human tumour biology and therapeutic development (abstract S13)

17:00

Closing by Kit Byatt, DHT Chair of the Trustees

17:15

Drinks reception